{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T12:56:43Z","timestamp":1756385803497},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,2,20]]},"DOI":"10.7759\/cureus.13460","type":"journal-article","created":{"date-parts":[[2021,2,21]],"date-time":"2021-02-21T00:02:26Z","timestamp":1613865746000},"source":"Crossref","is-referenced-by-count":0,"title":["Abatacept-Induced Panniculitis With Necrobiosis Lipoidica-Like Features in a Patient With Rheumatoid Arthritis"],"prefix":"10.7759","author":[{"given":"Scott","family":"Mahlberg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thao","family":"Pham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brittney","family":"DeClerck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gloria J","family":"Stevens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diem Q","family":"Pham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"crossref","DOI":"10.5070\/D3204022376","article-title":"Erythema nodosum - a review of an uncommon panniculitis","volume":"20","author":"Blake T","year":"2014","unstructured":"Blake T, Manahan M , Rodins K. Erythema nodosum - a review of an uncommon panniculitis. Dermatol Online J. 2014, 20:22376.","journal-title":"Dermatol Online J"},{"key":"ref2","article-title":"Drug-induced panniculitides","volume":"149","author":"Borroni G","year":"2014","unstructured":"Borroni G, Torti S, D'Ospina RM, Pezzini C. Drug-induced panniculitides. G Ital Dermatol Venereol. 2014, 149:263-270.","journal-title":"G Ital Dermatol Venereol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1080\/09546630600788885","article-title":"Abatacept: a review of a new biologic agent for refractory rheumatoid arthritis for dermatologists","volume":"17","author":"Scheinfeld N","year":"2006","unstructured":"Scheinfeld N. Abatacept: a review of a new biologic agent for refractory rheumatoid arthritis for dermatologists. J Dermatol Treat. 2006, 17:229-234. 10.1080\/09546630600788885","journal-title":"J Dermatol Treat"},{"key":"ref4","article-title":"Abatacept-induced lupus erythematosus panniculitis in a patient with rheumatoid arthritis","volume":"16","author":"Mong C","year":"2012","unstructured":"Mong C, Tsai M, Gharavi NM, Smart C, Lee DJ, Young L. Abatacept-induced lupus erythematosus panniculitis in a patient with rheumatoid arthritis. Proc UCLA Healthcare. 2012, 16:","journal-title":"Proc UCLA Healthcare"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/ajd.12185","article-title":"A case of abatacept associated neutrophilic dermatosis and a review of the literature","volume":"55","author":"Tiwari SM","year":"2014","unstructured":"Tiwari SM, Wood BA, Skender-Kalnenas T, Cook N. A case of abatacept associated neutrophilic dermatosis and a review of the literature. Australas J Dermatol. 2014, 55:214-217. 10.1111\/ajd.12185","journal-title":"Australas J Dermatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1159\/000335616","article-title":"Histopathological patterns indicative of distinct adverse drug reactions","volume":"97","author":"Kerl K","year":"2012","unstructured":"Kerl K. Histopathological patterns indicative of distinct adverse drug reactions. Chem Immunol Allergy. 2012, 97:61-78. 10.1159\/000335616","journal-title":"Chem Immunol Allergy"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.14554","article-title":"Sequential appearance of small vessel vasculitis and neutrophilic panniculitis in a patient with rheumatoid arthritis: further insight into the mechanism of this infrequent panniculitis","volume":"58","author":"Rodr\u00edguez\u2010Jim\u00e9nez P","year":"2019","unstructured":"Rodr\u00edguez\u2010Jim\u00e9nez P, Chicharro P, Reolid A, Mu\u00f1oz\u2010Aceituno E, Fraga J, Llamas\u2010Velasco M. Sequential appearance of small vessel vasculitis and neutrophilic panniculitis in a patient with rheumatoid arthritis: further insight into the mechanism of this infrequent panniculitis. Int J Dermatol. 2019, 58:e198-e200. 10.1111\/ijd.14554","journal-title":"Int J Dermatol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s10165-012-0774-y","article-title":"Cutaneous necrobiotic conditions associated with rheumatoid arthritis: important extra-articular involvement","volume":"23","author":"Yamamoto T","year":"2013","unstructured":"Yamamoto T. Cutaneous necrobiotic conditions associated with rheumatoid arthritis: important extra-articular involvement. Mod Rheumatol. 2013, 23:617-622. 10.1007\/s10165-012-0774-y","journal-title":"Mod Rheumatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/S1297-319X(09)74520-8","article-title":"Abatacept therapy and safety management","volume":"76","author":"Pham T","year":"2009","unstructured":"Pham T, Claudepierre P, Constantin A, et al.. Abatacept therapy and safety management. Joint Bone Spine. 2009, 76:S3-S55. 10.1016\/S1297-319X(09)74520-8","journal-title":"Joint Bone Spine"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/art.22070","article-title":"Safety of the selective costimulation modulator abatacept in rheumatoid arthritis patients receiving background biologic and nonbiologic disease-modifying antirheumatic drugs: a one-year randomized, placebo-controlled study","volume":"54","author":"Weinblatt M","year":"2006","unstructured":"Weinblatt M, Combe B, Covucci A, Aranda R, Becker JC, Keystone E. Safety of the selective costimulation modulator abatacept in rheumatoid arthritis patients receiving background biologic and nonbiologic disease-modifying antirheumatic drugs: a one-year randomized, placebo-controlled study. Arthritis Rheum. 2006, 54:2807-2816. 10.1002\/art.22070","journal-title":"Arthritis Rheum"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.00282","article-title":"Paradoxical skin reactions to biologics in patients with rheumatologic disorders","volume":"10","author":"Garcovich S","year":"2019","unstructured":"Garcovich S, De Simone C, Genovese G, Berti E, Cugno M, Marzano A. Paradoxical skin reactions to biologics in patients with rheumatologic disorders. Front Pharmacol. 2019, 10:282. 10.3389\/fphar.2019.00282","journal-title":"Front Pharmacol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.2007.02742.x","article-title":"Delayed drug hypersensitivity reactions ? New concepts","volume":"37","author":"Posadas SJ","year":"2007","unstructured":"Posadas SJ, Pichler WJ. Delayed drug hypersensitivity reactions ? New concepts. Clin Exp Allergy. 2007, 37:989-999. 10.1111\/j.1365-2222.2007.02742.x","journal-title":"Clin Exp Allergy"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.mmcr.2018.12.008","article-title":"Immune reconstitution inflammatory syndrome associated with disseminated histoplasmosis and TNF-alpha inhibition","volume":"23","author":"Wright T","year":"2019","unstructured":"Wright T, Coruh B, Fredricks D. Immune reconstitution inflammatory syndrome associated with disseminated histoplasmosis and TNF-alpha inhibition. Med Mycol Case Rep. 2019, 23:62-64. 10.1016\/j.mmcr.2018.12.008","journal-title":"Med Mycol Case Rep"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo CA","year":"1981","unstructured":"Naranjo CA, Busto U, Sellers EM, et al.. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981, 30:239-245. 10.1038\/clpt.1981.154","journal-title":"Clin Pharmacol Ther"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/41418-abatacept-induced-panniculitis-with-necrobiosis-lipoidica-like-features-in-a-patient-with-rheumatoid-arthritis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:34:05Z","timestamp":1707507245000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/41418-abatacept-induced-panniculitis-with-necrobiosis-lipoidica-like-features-in-a-patient-with-rheumatoid-arthritis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,20]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.13460","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2,20]]}}}